论文部分内容阅读
目的分析氯沙坦钾片治疗社区高血压合并高尿酸血症的临床疗效。方法随机选取所在医院2014年10月至2016年3月180例社区高血压合并高尿酸血症患者,随机分组,干预组患者采用氯沙坦钾片治疗,对照组采用缬沙坦胶囊治疗,对比2组患者临床治疗情况。结果干预组临床治疗总有效率为93.33%,对照组临床治疗总有效率为76.67%,2组疗效差异显著(P<0.05)。结论氯沙坦钾片临床效果明显,可明显缓解社区高血压合并高尿酸血症患者临床症状,值得临床推广。
Objective To analyze the clinical efficacy of losartan potassium tablets in the treatment of community-based hypertensive patients with hyperuricemia. Methods A total of 180 community hypertensive patients with hyperuricemia were randomly selected from the hospital from October 2014 to March 2016. Patients in the intervention group were treated with losartan potassium tablets and those in the control group were treated with valsartan capsules. 2 groups of patients with clinical treatment. Results The total effective rate was 93.33% in the intervention group and 76.67% in the control group. The difference between the two groups was significant (P <0.05). Conclusion Losartan potassium tablets have obvious clinical effect, which can obviously relieve the clinical symptoms of patients with hypertension and hyperuricemia in community and are worthy of clinical promotion.